Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Download your interactive eBook
Vital updates and insights into the increasingly important area of gene therapy. Stay current with the latest gene therapy developments as reported in Pink Sheet, In Vivo and Scrip. Topics in your free, interactive eBook include:
Scrip: industry news and insights
By Kevin Grogan 02 Aug 2021
The German biotech has raised a significant sum to advance its T-cell therapies for solid tumors developed using its transgenic...
Pink Sheet: global policy and regulatory coverage
By Ian Schofield 02 Aug 2021
It may not yet be approved for marketing, but UCB’s potential blockbuster psoriasis drug has already got the all-clear from...
Scrip: industry news and insights
By Jung Won Shin 02 Aug 2021
South Korean pharma HK inno.N’s $500m IPO has drawn strong interest with subscriptions from institutional investors marking a record high...
Request a Trial
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
Biomedtracker provides real-time analysis of major market-moving events in the pharma and biotech industries. With catalyst tracking and expert insights, Biomedtracker helps you stay on top of breaking events, the drugs pipeline, upcoming milestones, companies, and deals – and their impact on the markets you care about.
A well-respected and trusted industry source for the last 15 years, Generics Bulletin from Informa Pharma Intelligence provides in-depth news and analysis on issues that matter most to businesses across the generics, biosimilars and value-added medicines industries.
HBW Insight is a single source of regulatory, legislative, legal and commercial news and insight connecting the dots across 3 sectors, including over the counter medicines, vitamins and dietary supplements, and cosmetics, which have increasing points of intersection, helping you to anticipate global challenges, risks, and opportunities.
Looking for more products Product Finder
